Interesting survey on #biosimilars in #oncology: a survey by ⁦@myESMO⁩ just published in ⁦@ESMO_Open⁩ https://esmoopen.bmj.com/content/4/2/e000460

Novel #Oncology Drug Discovery Strategies -- http://ow.ly/5itc30o20dT https://t.co/dJUooNnFnb

Mutations in DNA Damage Repair Predict Benefit With Platinum Agents in Pancreatic Cancer http://www.ascopost.com/issues/march-10-2019/mutations-in-dna-damage-repair-predict-benefit-with-platinum-agents-in-pancreatic-cancer/ #pancsm #oncology #GI19

Intense Neoadjuvant Androgen Deprivation Before Prostatectomy in Locally Advanced Prostate Cancer http://www.ascopost.com/News/59826 #pcsm #oncology

The Pancreatic Cancer Collective Awards $7 Million to Teams of Researchers in Pancreatic Cancer http://www.ascopost.com/issues/march-10-2019/the-pancreatic-cancer-collective-awards-7-million-to-teams-of-researchers-in-pancreatic-cancer/ #pancsm #oncology

Pembrolizumab/Axitinib Combination Improves Outcomes vs Sunitinib in Kidney Cancer http://www.ascopost.com/issues/march-10-2019/pembrolizumabaxitinib-combination-improves-outcomes-vs-sunitinib-in-kidney-cancer/ #kcsm #oncology #GU19

miR-30c represses fibrin-mediated tumor angiogenesis https://buff.ly/2J7nwuW @UVACancerCenter @UNC_CBP #oncology… https://twitter.com/i/web/status/1105473529074593798

Get the latest articles from top researchers in Future #Oncology FREE! Find out more http://www.futuremedicine.com/journal/fon

ARAMIS Trial Reports Darolutamide Improves Outcomes in High-Risk Nonmetastatic Prostate Cancer http://www.ascopost.com/issues/march-10-2019/aramis-trial-reports-darolutamide-improves-outcomes-in-high-risk-nonmetastatic-prostate-cancer/ #pcsm #oncology

Lack of Genetic Diversity in Common Cancer Cell Lines http://www.ascopost.com/News/59828 #oncology